Ukay Remedys Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 16-11-2024
- Paid Up Capital ₹ 4.00 M
as on 16-11-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.69 Cr
as on 16-11-2024
- Revenue -26.15%
(FY 2023)
- Profit -33.44%
(FY 2023)
- Ebitda -0.72%
(FY 2023)
- Net Worth 9.74%
(FY 2023)
- Total Assets 48.58%
(FY 2023)
About Ukay Remedys
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹4.69 Cr.
Rakshet Dalani, Usha Dalani, Vinod Dalani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2008PTC182718
- Company No.
182718
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ukay Remedys?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Dalani  | Director | 27-May-2008 | Current |
| Rakshet Dalani | Director | 18-Feb-2020 | Current |
| Usha Dalani | Director | 07-May-2009 | Current |
| Vinod Dalani | Director | 27-May-2008 | Current |
Financial Performance of Ukay Remedys.
Ukay Remedys Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.15% decrease. The company also saw a substantial fall in profitability, with a 33.44% decrease in profit. The company's net worth moved up by a moderate rise of 9.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ukay Remedys?
In 2022, Ukay Remedys had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Sep 2024 | ₹3.75 Cr | Open |
Canara Bank Creation Date: 14 Oct 2020 | ₹1.00 M | Open |
State Bank Of India Creation Date: 16 Dec 2008 | ₹8.40 M | Open |
How Many Employees Work at Ukay Remedys?
Unlock and access historical data on people associated with Ukay Remedys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ukay Remedys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ukay Remedys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
